Published in Circulation on June 12, 2001
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Pleiotropic effects of statins. - Basic research and clinical perspectives -. Circ J (2010) 2.13
Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest (2006) 1.55
Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha. Mol Pharmacol (2007) 1.35
Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia. J Immunol (2007) 1.35
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications. Expert Rev Cardiovasc Ther (2008) 1.30
Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J Biol Chem (2002) 1.28
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol (2004) 1.15
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet (2009) 1.11
Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab (2009) 1.04
Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol Immunotoxicol (2009) 1.03
Pediatric triglycerides predict cardiovascular disease events in the fourth to fifth decade of life. Metabolism (2009) 0.99
Current and future concepts in stroke prevention. CMAJ (2004) 0.99
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag (2008) 0.97
New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury. PPAR Res (2012) 0.94
Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol (2008) 0.93
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res (2009) 0.91
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA). BMC Public Health (2010) 0.88
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids Health Dis (2005) 0.87
Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.86
Treatment of risk factors to prevent stroke. Neurotherapeutics (2011) 0.86
Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology. Int J Cell Biol (2012) 0.86
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. PPAR Res (2008) 0.83
Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. Curr Vasc Pharmacol (2014) 0.82
Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clin Proc (2009) 0.81
Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP. J Lipid Res (2008) 0.79
Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World J Diabetes (2014) 0.79
Lipids and Cerebrovascular Disease: Research and Practice. Stroke (2015) 0.78
Master autophagy regulator Transcription factor-EB (TFEB) regulates cigarette smoke induced autophagy-impairment and COPD-emphysema pathogenesis. Antioxid Redox Signal (2016) 0.78
Management of extracranial carotid artery disease. Cardiol Clin (2015) 0.78
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease. Clin Biochem Rev (2004) 0.77
The selective PPARα modulator K-877 efficiently activates the PPARα pathway and improves lipid metabolism in mice. J Diabetes Investig (2017) 0.76
Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial. Curr Ther Res Clin Exp (2004) 0.75
All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. Data Brief (2016) 0.75
Study of atherogenic lipid profile, high sensitive C-reactive protein neurological deficit and short-term outcome in stroke subtypes. Iran J Neurol (2016) 0.75
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science (1994) 11.22
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
Isolated single coronary artery: diagnosis, angiographic classification, and clinical significance. Radiology (1979) 6.95
Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke (1995) 6.49
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56
Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature (1988) 3.27
Current trends in microsatellite genotyping. Mol Ecol Resour (2011) 3.21
Drosophila mushroom body mutants are deficient in olfactory learning. J Neurogenet (1985) 3.19
Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke (2001) 3.17
Stratified randomization for clinical trials. J Clin Epidemiol (1999) 3.16
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA (1991) 2.71
Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A (2000) 2.46
Organization of the ribosomal ribonucleic acid genes in various wild-type strains and wild-collected strains of Neurospora. Mol Gen Genet (1984) 2.35
Seasonal fluctuation in the incidence of intracranial aneurysm rupture and its relationship to changing climatic conditions. J Neurosurg (1994) 2.26
Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med (1990) 2.23
Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery (1998) 2.22
Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. J Clin Microbiol (1997) 2.18
Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med (1996) 2.15
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. Radiology (1998) 2.12
E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA (2000) 2.07
Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study. Am J Epidemiol (1997) 2.04
Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke (2000) 1.97
Skin cancer and water arsenic in Lane County, Oregon. Cancer (1976) 1.95
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93
Explaining math: gesturing lightens the load. Psychol Sci (2001) 1.92
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke (1998) 1.85
Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet (1994) 1.80
Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology (1994) 1.76
Severity of coronary artery disease in black and white male veterans and likelihood of revascularization. Am Heart J (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Development of a test battery to identify older drivers at risk for self-reported adverse driving events. J Am Geriatr Soc (1998) 1.74
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int (1995) 1.74
Separation of phospholipids and individual molecular species of phospholipids by high-performance liquid chromatography. J Lipid Res (1982) 1.72
Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta (1995) 1.67
Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest (2000) 1.65
The efficacy of SNOMED, Read Codes, and UMLS in coding ambulatory family practice clinical records. Proc AMIA Annu Fall Symp (1996) 1.65
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Velocity of blood flow in normal human venae cavae. Circ Res (1968) 1.64
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology (2000) 1.63
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
New anatomical and functional imaging methods. Ann Neurol (1992) 1.61
Genetic analysis of brain circuits underlying pheromone signaling. Annu Rev Genet (2006) 1.60
Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension (1995) 1.58
Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology (1996) 1.58
The initial effects of a cervical spine manipulative physiotherapy treatment on the pain and dysfunction of lateral epicondylalgia. Pain (1996) 1.56
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab (2001) 1.53
[Laryngeal tube versus laryngeal mask airway in anaesthetised non-paralysed patientsA comparison of handling and postoperative morbidity]. Anaesthesist (2004) 1.52
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology (2005) 1.52
Lessons from history. Why radiologists lost coronary angiography and what can be done to prevent future similar losses. Invest Radiol (1994) 1.51
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51
Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients. Radiology (1985) 1.51
Binswanger's disease: a review. Stroke (1987) 1.50
Successful treatment of a saphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv (1999) 1.47
An investigation of the interrelationship between manipulative therapy-induced hypoalgesia and sympathoexcitation. J Manipulative Physiol Ther (1998) 1.47
A human nuclear-localized chaperone that regulates dimerization, DNA binding, and transcriptional activity of bZIP proteins. Mol Cell (1999) 1.47
Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med (1995) 1.47
Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology (2009) 1.46
A model for faculty mentoring in academic radiology. Acad Radiol (2000) 1.45
Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging. Radiology (1990) 1.45
Good vibrations: oscillatory phase shapes perception. Neuroimage (2012) 1.45
Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med (1995) 1.44
Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature (1995) 1.44
Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44
Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology (2003) 1.43
Hepatitis B vaccination of high-risk individuals in the canton of Zurich. Eur J Clin Microbiol (1983) 1.43
Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol (1984) 1.43
Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am J Cardiol (1977) 1.42
Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol (1991) 1.42
The VA HDL intervention trial: clinical implications. Eur Heart J (2000) 1.41
Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ (1995) 1.41
Coronary arterial narrowing in Takayasu's aortitis. Am J Cardiol (1977) 1.40
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J (1990) 1.40
Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs. Radiology (1997) 1.40
Incidence of visits by badgers to farmyards in Ireland in winter. Vet Rec (2008) 1.39
Electrocardiographic abnormalities suggestive of myocardial ischemia during upper gastrointestinal bleeding. Am J Cardiol (1995) 1.39
Monorail system for percutaneous repositioning of the Greenfield vena caval filter. Radiology (1990) 1.39
Activating transcription factor-1 can mediate Ca(2+)- and cAMP-inducible transcriptional activation. J Biol Chem (1993) 1.39
Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India. Indian J Med Res (2007) 1.39
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood (2001) 1.38
Congenital diaphragmatic hernia associated with aortic coarctation. J Pediatr Surg (1998) 1.38
Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab (2001) 1.37
Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol (1995) 1.36
Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis (2000) 1.34
Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. J Lab Clin Med (1985) 1.32
Purine nucleoside phosphorylase. 1. Structure-function studies. Biochemistry (1997) 1.30